Latest therapeutics News | Page 4

World first trial for kids with Duchenne Muscular Dystrophy
NSW new world first trial for kids with Duchenne Muscular Dystrophy
Restoring Lost Sense of Smell
Early-Stage Innovation Forum opens
New anti-inflammatory drug – one medicine to rule them all
RNA – changing face of modern medicine
Cynata Therapeutics announces CEO succession and board changes
Takeda’s COCKPI-T programme calls for applications
University spinout signs agreement on Alzheimer’s disease biomarkers
NSW new first look at Australia’s first purpose-built Biocontainment Centre
New venom discovery from deadly cone snails
The Oligonucleotide Therapeutics Society is Pleased to Announce the 2023 Annual Meeting in Barcelona, Spain
Researchers develop a new approach to scale-up manufacturing of life-saving oligonucleotide therapeutics
Top performing ASX life science companies
Psychedelic-assisted therapy clinic GoodMind Therapeutics launches in Australia to offer hope for depression and PTSD sufferers
Infectious Disease Institute Now Step Closer
AstraZeneca announces agreement with Quell Therapeutics to develop, manufacture and commercialise engineered T-regulatory cell therapies for autoimmune diseases
Medicinal cannabis is a ‘life-changing treatment’ for people with Tourette syndrome
Stakeholders meet in WHO to review progress towards elimination of human African trypanosomiasis
New Monash Spinout Resseptor Therapeutics Launches With AU$2.25M Investment From IP Group
University of Enterprise on mission to expand biotech partnerships
Enhertu demonstrated clinically meaningful and durable responses in patients across multiple HER2-expressing advanced solid tumours
Zelira Therapeutics announces the appointment of new non-executive director
Chimeric Therapeutics announces new trial for CHM 1101 in glioblastoma
Elizabeth Johnson wins inaugural Schwartz visionary grant
Major development for cancer-killing ‘Masterswitch’ discovery
Kazia Therapeutics participates in ‘Cancer Moonshot Brain Cancers’ forum
Best early-stage project at awarded at AusMedtech 2023
AI drug discovery will power collaboration with Pharos Therapeutics
Funnel-web spider venom varies
KAZIA CEO, DR JOHN FRIEND PARTICIPATES IN WHITE HOUSE CANCER MOONSHOT FORUM Brain Cancers Forum on Glioblastoma & Diffuse Intrinsic Pontine Glioma Forum
CSIRO launches free SME programme
Brightest minds power quest for brain cancer cure
$3.4M grant to tackle ‘biggest challenge’ to HIV cure
Strengthening influenza preparedness through OpenWHO online course
Researchers Modify Drug to Enter Cells and Treat Pain
New human epigenetics laboratory
Chimeric Therapeutics announces new capital raise
New report calls on national cell and gene therapy plan
Release of Te Rau Ora Equity Review
Funding for early screening and improved treatments for deadly lung disease
Amplia Therapeutics says third cohort enrolment completed in ACCENT clinical trial
UWA and Bridgewest Perth Pharma announce new partnership
LBT Innovations begins search for new board chair
Antisense Therapeutics announces the appointment of new CEO and managing director
Sydney spinout lands $273m deal to develop drugs for psychiatric disorders
Patent granted in India and Notice of Allowance Issued in Israel for CLTX Car Technology
World-changing research on show at inaugural symposium